{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:50:25Z","timestamp":1762098625152,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lockdown measures due to the COVID-19 pandemic have led to lifestyle changes, which in turn may have an impact on the course of headache disorders. We aimed to assess changes in primary headache characteristics and lifestyle factors during the COVID-19 lockdown in Germany using digital documentation in the mobile application (app) M-sense.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main body<\/jats:title>\n                <jats:p>We analyzed data of smartphone users, who entered daily data in the app in the 28-day period before lockdown (baseline) and in the first 28\u2009days of lockdown (observation period). This analysis included the change of monthly headache days (MHD) in the observation period compared to baseline. We also assessed changes in monthly migraine days (MMD), the use of acute medication, and pain intensity. In addition, we looked into the changes in sleep duration, sleep quality, energy level, mood, stress, and activity level. Outcomes were compared using paired t-tests.<\/jats:p>\n                <jats:p>The analysis included data from 2325 app users. They reported 7.01\u2009\u00b1\u2009SD 5.64 MHD during baseline and 6.89\u2009\u00b1\u20095.47 MHD during lockdown without significant changes (<jats:italic>p<\/jats:italic>\u00a0&gt;\u20090.999). MMD, headache and migraine intensity neither showed any significant changes. Days with acute medication use were reduced from 4.50\u2009\u00b1\u20093.88 in the baseline to 4.27\u2009\u00b1\u20093.81 in the observation period (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.001). The app users reported reduced stress levels, longer sleep duration, reduced activity levels, along with a better mood, and an improved energy level during the first\u00a0lockdown\u00a0month (<jats:italic>p<\/jats:italic>\u00a0\u2264\u20090.001).<\/jats:p>\n                <jats:p>In an extension analysis of users who continued to use M-sense every day for 3 months after initiation of lockdown, we compared the baseline and the subsequent months using repeated-measures ANOVA. In these 539 users, headache frequency did not change significantly neither (6.11\u2009\u00b1\u20095.10 MHD before lockdown vs. 6.07\u2009\u00b1\u20095.17 MHD in the third lockdown month, <jats:italic>p<\/jats:italic>\u00a0=\u20090.688 in the ANOVA). Migraine frequency, headache and migraine intensity, and acute medication use were also not different during the entire observation period.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Despite slight changes in factors that contribute to the generation of headache, COVID-19-related lockdown measures did not seem to be associated with primary headache frequency and intensity over the course of 3 months.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10194-021-01273-z","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T14:03:18Z","timestamp":1624370598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Primary headaches during the COVID-19 lockdown in Germany: analysis of data from 2325 patients using an electronic headache diary"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9758-1494","authenticated-orcid":false,"given":"Bianca","family":"Raffaelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasper","family":"Mecklenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Scholler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Hendrik","family":"Overeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Sofia","family":"Oliveira Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Neeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"issue":"6","key":"1273_CR1","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1177\/0333102417727535","volume":"38","author":"ABW Pellegrino","year":"2018","unstructured":"Pellegrino ABW, Davis-Martin RE, Houle TT, Turner DP, Smitherman TA (2018) Perceived triggers of primary headache disorders: a meta-analysis. Cephalalgia. 38(6):1188\u20131198","journal-title":"Cephalalgia."},{"issue":"2","key":"1273_CR2","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 97(2):553\u2013622","journal-title":"Physiol Rev"},{"key":"1273_CR3","unstructured":"Die Bundesregierung. Besprechung der Bundeskanzlerin mit den Regierungschefinnen und Regierungschefs der L\u00e4nder. https:\/\/www.bundesregierung.de\/breg-de\/themen\/coronavirus\/besprechung-der-bundeskanzlerin-mit-den-regierungschefinnen-und-regierungschefs-der-laender-1733248. Accessed 18 Dec 2020"},{"key":"1273_CR4","unstructured":"Die Bundesregierung. Schulen und Gesch\u00e4fte \u00f6ffnen schrittweise. https:\/\/www.bundesregierung.de\/breg-de\/themen\/coronavirus\/aktuelle-massnahmen-1745170. Accessed 18 Dec 2020"},{"key":"1273_CR5","unstructured":"Handelsblatt. Coronavirus: So hat sich die Lungenkrankheit in Deutschland entwickelt. https:\/\/www.handelsblatt.com\/politik\/deutschland\/covid-19-in-deutschland-coronavirus-so-hat-sich-die-lungenkrankheit-in-deutschland-entwickelt\/25584942.html?ticket=ST-3754816-hcCem5cGwGIavNd7s2XS-ap5. Accessed 13 May 2021"},{"key":"1273_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.bbi.2020.05.048","volume":"89","author":"N Vindegaard","year":"2020","unstructured":"Vindegaard N, Benros ME (2020) COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behav Immun 89:531\u2013542","journal-title":"Brain Behav Immun"},{"key":"1273_CR7","doi-asserted-by":"publisher","first-page":"112958","DOI":"10.1016\/j.psychres.2020.112958","volume":"288","author":"SX Zhang","year":"2020","unstructured":"Zhang SX, Wang Y, Rauch A, Wei F (2020) Unprecedented disruption of lives and work: health, distress and life satisfaction of working adults in China one month into the COVID-19 outbreak. Psychiatry Res 288:112958","journal-title":"Psychiatry Res"},{"issue":"5","key":"1273_CR8","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/head.13810","volume":"60","author":"CL Szperka","year":"2020","unstructured":"Szperka CL, Ailani J, Barmherzig R, Klein BC, Minen MT, Halker Singh RB et al (2020) Migraine Care in the era of COVID-19: clinical pearls and Plea to insurers. Headache. 60(5):833\u2013842","journal-title":"Headache."},{"issue":"2","key":"1273_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0197-2456(02)00320-3","volume":"24","author":"AA Stone","year":"2003","unstructured":"Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR (2003) Patient compliance with paper and electronic diaries. Control Clin Trials 24(2):182\u2013199","journal-title":"Control Clin Trials"},{"issue":"1","key":"1273_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s10194-020-01139-w","volume":"21","author":"A Roesch","year":"2020","unstructured":"Roesch A, Dahlem MA, Neeb L, Kurth T (2020) Validation of an algorithm for automated classification of migraine and tension-type headache attacks in an electronic headache diary. J Headache Pain 21(1):75","journal-title":"J Headache Pain"},{"issue":"1","key":"1273_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1\u2013211","journal-title":"Cephalalgia"},{"issue":"8","key":"1273_CR12","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s10072-020-04543-x","volume":"41","author":"IC Parodi","year":"2020","unstructured":"Parodi IC, Poeta MG, Assini A, Schirinzi E, Del Sette P (2020) Impact of quarantine due to COVID infection on migraine: a survey in Genova, Italy. Neurol Sci 41(8):2025\u20132027","journal-title":"Neurol Sci"},{"key":"1273_CR13","doi-asserted-by":"publisher","first-page":"597881","DOI":"10.3389\/fneur.2020.597881","volume":"11","author":"M Delussi","year":"2020","unstructured":"Delussi M, Gentile E, Coppola G, Prudenzano AMP, Rainero I, Sances G et al (2020) Investigating the effects of COVID-19 quarantine in migraine: an observational cross-sectional study from the Italian National Headache Registry (RICe). Front Neurol 11:597881","journal-title":"Front Neurol"},{"key":"1273_CR14","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1177\/0333102420981739","volume":"41","author":"IE Verhagen","year":"2021","unstructured":"Verhagen IE, van Casteren DS, de Vries LS, Terwindt GM (2021) Effect of lockdown during COVID-19 on migraine: a longitudinal cohort study. Cephalalgia. 41:865","journal-title":"Cephalalgia."},{"issue":"1","key":"1273_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10194-020-01106-5","volume":"21","author":"A MaassenVanDenBrink","year":"2020","unstructured":"MaassenVanDenBrink A, de Vries T, Danser AHJ (2020) Headache medication and the COVID-19 pandemic. J Headache Pain. 21(1):38","journal-title":"J Headache Pain."},{"key":"1273_CR16","doi-asserted-by":"crossref","unstructured":"Majumdar et al (2020) COVID-19 pandemic and lockdown: cause of sleep disruption, depression, somatic pain, and increased screen exposure of office workers and students of India. Chronobiol Int 37(8):1191\u20131200","DOI":"10.1080\/07420528.2020.1786107"},{"key":"1273_CR17","doi-asserted-by":"crossref","unstructured":"Capuano et al (2020) Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? J Neurol 268(3):743\u2013750","DOI":"10.1007\/s00415-020-10099-9"},{"issue":"18","key":"1273_CR18","doi-asserted-by":"publisher","first-page":"6878","DOI":"10.3390\/ijerph17186878","volume":"17","author":"A Casta\u00f1eda-Babarro","year":"2020","unstructured":"Casta\u00f1eda-Babarro A, Arbillaga-Etxarri A, Guti\u00e9rrez-Santamar\u00eda B, Coca A (2020) Physical activity change during COVID-19 confinement. Int J Environ Res Public Health 17(18):6878","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"1273_CR19","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/nu12061583","volume":"12","author":"A Ammar","year":"2020","unstructured":"Ammar A, Brach M, Trabelsi K, Chtourou H, Boukhris O, Masmoudi L et al (2020) Effects of COVID-19 home confinement on eating behaviour and physical activity: results of the ECLB-COVID19 international online survey. Nutrients 12(6):1583","journal-title":"Nutrients"},{"key":"1273_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.puhe.2020.06.042","volume":"185","author":"M Schnitzer","year":"2020","unstructured":"Schnitzer M, Sch\u00f6ttl SE, Kopp M, Barth M (2020) COVID-19 stay-at-home order in Tyrol, Austria: sports and exercise behaviour in change? Public Health 185:218\u2013220","journal-title":"Public Health"},{"key":"1273_CR21","unstructured":"Raffaelli B, Mecklenburg J, Overeem LH, Scholler S, Dahlem MA, Kurth T, et al (2021) Daily electronic headache diary via a smartphone app: observational study of headache evolution among regular users. JMIR mHealth and uHealth (accepted for publication)"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-021-01273-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-021-01273-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-021-01273-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T14:03:27Z","timestamp":1624370607000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-021-01273-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1273"],"URL":"https:\/\/doi.org\/10.1186\/s10194-021-01273-z","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"type":"print","value":"1129-2369"},{"type":"electronic","value":"1129-2377"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"assertion":[{"value":"18 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Upon installation, M-sense users agree to the use of their data in anonymous form for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/a","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BR reports research grants from Novartis, and personal fees from Hormosan, Novartis, Teva, and Allergan. JM reports personal fees from Novartis. SS is Chief Product Officer of Newsenselab. ASOG has nothing to disclose. LN contributed to advisory boards of Hormosan, Lilly, Novartis and TEVA, and received speaking fees from Allergan, Biogen, Hormosan, Lilly, Novartis and TEVA. UR received honoraria for consulting and lectures from Amgen, Allergan, Abbvie, Eli Lilly, Lundbeck, Novartis Pharma, electroCore, Medscape, Novartis, StreaMedUp, and Teva; UR received research funding from BMBF and Novartis Pharma.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}